RxDoctor Payments DataLook up a doctor →

Jorge Navas, MD

Cardiovascular Disease · Clearwater, FLNPI 1861481368

Payments from drug & device makers

$1,604,034in general payments, 2019–2025

Across 108 payments — averaging $14,852 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.3M
  • Janssen Research & Development, LLC$319K
  • Boehringer Ingelheim International GmbH$11K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$7K
  • Medtronic$230
  • Pfizer$123
  • plus $592 from 13 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,604,034 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Medicare billing

Part B allowed, 2024
$698,436
Medicare patients
1,794
Services billed
17,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →